Multiple Sclerosis Clinical Trials in Phoenix

Showing 361-380 of 490 trials

Atorvastatin (Lipitor) Therapy in Patients With Clinically Isolated Syndrome (CIS) at Risk for Multiple Sclerosis

NCT00094172

Patients who have been diagnosed with clinically isolated syndrome (CIS) often develop problems related to the central nervous system, which controls the nerves in the body. Some of these patients may later be diagnosed with multiple sclerosis (MS), a progressive disease of the nervous system. The purpose of this study is to determine if the drug atorvastatin is helpful to CIS patients. Study hypothesis: Early intervention with atorvastatin in patients with CIS will result in a state of immunological tolerance.

Multiple Sclerosis

National Institute of Allergy and Infectious Diseases (NIAID)82 participantsStarted May 2005

Phoenix, Arizona, United States • Los Angeles, California, United States • San Francisco, California, United States +11 more locations

COMPLETEDPhase 3< 1 mile

Natalizumab Re-Initiation of Dosing

NCT00306592

The primary objectives of this study are to further evaluate the safety of natalizumab (Tysabri®) monotherapy by evaluating the risk of hypersensitivity and immunogenicity following re-exposure to natalizumab, and to confirm the safety of switching to natalizumab from interferon beta (IFN-β), glatiramer acetate (GA), or other multiple sclerosis (MS) therapies.

Multiple Sclerosis, Relapsing-Remitting

Biogen404 participantsStarted Mar 2006

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Scottsdale, Arizona, United States +60 more locations

Atorvastatin (Lipitor) Therapy in Patients With Clinically Isolated Syndrome (CIS) at Risk for Multiple Sclerosis

Natalizumab Re-Initiation of Dosing

Multiple Sclerosis Trials in Other Cities

JC Virus Antibody Study of Participants With Relapsing Forms of MS Receiving Treatment With Natalizumab

Study of LY2784544 Testing Alternative Dosing in Participants With Myeloproliferative Neoplasms

Phase 4 Gastrointestinal Tolerability Study of Dimethyl Fumarate in Patients With Relapsing Forms of Multiple Sclerosis in the United States

Safety and Efficacy of Natalizumab in the Treatment of Multiple Sclerosis

Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Previously Treated Metastatic Colorectal Cancer

Lapatinib +/- Trastuzumab In Addition To Standard Neoadjuvant Breast Cancer Therapy.

Randomized Study Comparing Docetaxel Plus Dasatinib to Docetaxel Plus Placebo in Castration-resistant Prostate Cancer

Bone Graft Materials Observational Registry

A Multiple Ascending Dose Study of R1530 in Patients With Advanced Solid Tumors.

Efficacy and Safety of GTR in Comparison to Copaxone®

A Study of RO5045337 [RG7112] in Patients With Hematologic Neoplasms.

EPO906 Therapy in Patients With Prostate Cancer

A Study of DOXIL/CAELYX in Patients With Advanced or Refractory Solid Malignancies Including Patients With Ovarian Cancer

Safety, Tolerability, and Pharmacokinetics of Onartuzumab Combined With Vemurafenib and/or Cobimetinib in Cancer Patients

JC-Virus (JCV) Antibody Program

A Pharmacokinetics (PK) Study to Investigate the Effect of Rifampin on PK of Vemurafenib (Zelboraf)

Zenith(R) Fenestrated Abdominal Aortic Aneurysm (AAA) Endovascular Graft Clinical Study

Tolerability and Safety and Health Outcomes in Relapsing Multiple Sclerosis (MS) Patients

Other Conditions in Phoenix